Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Same-day chemotherapy boosts cancer vaccine responses in preclinical models

Both the clinical effects and the unpleasant side effects of chemotherapies, from hair loss to mouth sores to gastrointestinal discomfort, stem from their indiscriminate destruction of cells prone to rapid proliferation. That includes CD8+ T cells, the body's frontline soldiers against viral infections and cancer, which multiply furiously when they're activated by their target antigens.

Same-day chemotherapy boosts cancer vaccine responses in preclinical models

Researchers have discovered a previously unknown mechanism by which certain chemotherapies can boost the effectiveness of cancer vaccines in preclinical studies. The study, led by Laurine Noblecourt, Amanda Wicki, and Benoit Van den Eynde at the Oxford Branch of the Ludwig Institute for Cancer Research, shows that the combination of carboplatin and paclitaxel (CarboTaxol) with cyclophosphamide can function as adjuvants that amplify the effects of cancer vaccines.

The researchers found that administering CarboTaxol on the same day as the vaccine enhances the vaccine's efficacy by expanding a pool of CD8+ T cells that express a factor known as TCF1. These T cells are crucial for initiating and sustaining anticancer immune responses. The timing of chemotherapy administration is crucial, as its adjuvant effect was only observed when given on the same day as the vaccine.

The study also reveals that TCF1+ CD8+ T cell expansion could be seen in patient samples from two independent cohorts of cancer patients treated with CarboTaxol, supporting the potential clinical relevance of these findings. Overall, this research highlights the potential of combining cancer vaccines, chemotherapy, and immune checkpoint blockade to enhance tumor control and improve survival rates.

Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Friday 2 October →